Delivery Order SPE2DB22D3016-SPE2DB25FAUE9

Award Date 4/20/25
Potential Completion Date 4/21/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,065.17 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Aranesp 500 mcg/1 mL syringes to support federal healthcare programs. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract has a ceiling value of $1,313.92 and a performance period through March 11, 2024. It covers the delivery of Aranesp, a specialty pharmaceutical drug, in 40 mcg/0.4 mL syringes. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,378.10 firm fixed-price delivery order is for the supply of Aranesp 60 mcg/0.3 mL syringes, a medication used to treat anemia. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a $5,691.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Aranesp 200 MCG/0.4 ML syringes, a specialty medication used for the treatment of anemia. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,648.97 firm fixed-price contract is for the delivery of Aranesp 100 mcg/0.5 ml syringes, a medication used to treat anemia. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC provides a...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,564,436,598 units of Aranesp 200 MCG/0.4 ML syringes. The contract has a firm fixed price of $4,651.10 and a period of performance ending on April 30, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distribution company that holds a large Indefinite Delivery Contract...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for 4,565,584,312 units of the pharmaceutical product ARANESP 500 MCG/1 ML SYRINGEML at a firm fixed price of $21,188.82. The contract has an ultimate completion date of August 27, 2024 and was awarded on August 26, 2024. AmerisourceBergen is a major supplier of pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical sourcing and distribution company. The $2,299.36 award is for the supply of Aranesp 40 MCG/0.4 ML syringes, with a completion date of February 15, 2024. This delivery order falls under an indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Aranesp, a medication used to treat anemia, with a ceiling value of $1,142.44. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,195.62 firm fixed-price contract is for the delivery of ARANESP 100 MCG/ML VIALML, a medication used to treat anemia. The contract has an ultimate completion date of November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAUE9
    Delivery Order

This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,100.80, is for the supply of 4,567,973,029 units of the drug Aranesp (darbepoetin alfa) 60 mcg/0.3 mL syringe. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This delivery order is not set aside and represents open competition. Amerisourcebergen, as the prime contractor, will be responsible for fulfilling the order, which is intended to support federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/21/25, 4:51 PM